Form 4: Clorox Executive Kevin B. Jacobsen Reports Acquisition of Common Stock

EVP and CFO of Clorox, Kevin B. Jacobsen, reports acquiring 6,800 shares of common stock at $164.69 per share.

Summary

• Kevin B. Jacobsen, EVP and Chief Financial Officer of Clorox, filed a Form 4 with the SEC.
• The report details the acquisition of 6,800 shares of Clorox common stock on September 17, 2024, at a price of $164.69 per share.
• Following the transaction, Jacobsen directly owns 40,720 shares of Clorox common stock.
• Jacobsen also indirectly owns 25 shares through an IRA and 3,145 shares through a trust.
• The report also mentions restricted stock units that will vest in four equal installments starting October 5, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An executive purchasing shares suggests confidence, but it's a single transaction and doesn't guarantee future success.

Positives

• An executive's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units extends to October 2028, indicating a long-term incentive for the executive.

Industry Context

Insider transactions are closely monitored as they can provide insights into a company's prospects, although they don't always predict future performance.

Comparison to Industry Standards

• Executive stock ownership is a common practice among publicly traded companies like Procter & Gamble (PG) and Unilever (UL), aligning management's interests with shareholders'.
• The vesting schedules for restricted stock units are generally in line with industry norms, often spanning several years to incentivize long-term performance.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a top executive.

Key Dates